PRESENTATION

Q4 FY2025 — Presentation

Q4 FY2025PDF · 20 pages1.5 MB
1 | CACI Proprietary Information
EXPERTISE and TECHNOLOGY
for National Security
EXPERTISE and TECHNOLOGY for National Security
CACI International Inc
Q4 FY25 Earnings Conference Call
August 7, 2025

-- 1 of 20 --

2 | CACI Proprietary Information
Forward-looking statements
There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward-looking statements as
that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to risk factors that could cause actual
results to be materially different from anticipated results. These risk factors include, but are not limited to, the following: our reliance on U.S.
government contracts, which includes general risk around the government contract procurement process (such as bid protest, small business
set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations
for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary
spending levels or budget priorities, such as for homeland security or to address global pandemics; legal, regulatory, and political change from
successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current agreements with
other nations, foreign events, or any other events which may affect the global economy, including the impact of global pandemics; the results
of government audits and reviews conducted by the Defense Contract Audit Agency, the Defense Contract Management Agency, or other
governmental entities with cognizant oversight; competitive factors such as pricing pressures and/or competition to hire and retain employees
(particularly those with security clearances); failure to achieve contract awards in connection with re-competes for present business and/or
competition for new business; regional and national economic conditions in the United States and globally, including but not limited to:
terrorist activities or war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation
regarding our continued independence; our ability to meet contractual performance obligations, including technologically complex obligations
dependent on factors not wholly within our control; limited access to certain facilities required for us to perform our work, including during a
global pandemic; changes in tax law, the interpretation of associated rules and regulations, or any other events impacting our effective tax rate;
changes in technology; the potential impact of the announcement or consummation of a proposed transaction and our ability to successfully
integrate the operations of our recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business
plans; the effects of health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position,
results of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings.

-- 2 of 20 --

3 | CACI Proprietary Information
On today’s call
John Mengucci
President and
Chief Executive Officer
Jeff MacLauchlan
Chief Financial Officer
and Treasurer

-- 3 of 20 --

4 | CACI Proprietary Information
Honoring the Legacy
of Mike Daniels
4 | CACI Proprietary Information

-- 4 of 20 --

5 | CACI Proprietary Information
Predictable
organic revenue
growth
16% underlying1 revenue
growth (10% organic)
$10 billion of contract
awards (1.1x TTM B2B)
Profitability
supportive
of continued
investment
11.2% EBITDA2 margin
Efficient
management of
working capital and
capital expenditures
$442 million
of free cash flow2
16% growth in
free cash flow per share
Flexible and
opportunistic
capital
deployment
Three strategic
acquisitions
Repurchased 436k shares
(avg. price of $344)
Exceptional FY24 Performance
FY25 success driven by our strategy, differentiation, and resilience
FY25 highlights
1 Excluding non-recurring $200M of no-margin material revenue in first half of FY24.
2 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 5 of 20 --

6 | CACI Proprietary Information
Counter-UAS	Electromagnetic Spectrum
• Leading with commercially-developed
and commercially-sold, software-
defined technology
• TLS Manpack one of Army’s first rapid
fielding mid-tier acquisitions
• Primary SIGINT/EW system for all
Brigade Combat Teams
• C-UAS technology demand increasing
(defense, border, and international)
• Continuing to invest ahead of customer
need, including for Golden Dome
• Decades of experience and thousands
of sensors deployed globally
Strategy, differentiation, and execution at work
Software Modernization
• Positioned to deliver additional
efficiencies through legacy system
consolidation like on IPPS-Army
• Commercial software development
processes incl. Agile and DevSecOps
• NCAPS ramping, has met ALL key
system availability metrics
Software-based capabilities and investment ahead of need position CACI well

-- 6 of 20 --

7 | CACI Proprietary Information
• Healthy demand and strong pipeline
in our markets
• CACI well-positioned to address geopolitical
realities and administration priorities
• Constructive budget environment and
One Big Beautiful Bill Act funding
• Comfortable operating in a continuing resolution
environment
Macro environment
7 | CACI Proprietary Information

-- 7 of 20 --

8 | CACI Proprietary Information
• Revenue growth of nearly 8% at the
midpoint (range of 6.6% to 8.9%)
• EBITDA Margin1 in the “mid 11% range”
• Free Cash Flow1 and Free Cash Flow per
Share growth of more than 60%
• Continued business momentum,
robust pipeline, and constructive macro
environment
• Continued confidence in 3-year financial
targets
FY26 look ahead
8 | CACI Proprietary Information 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 8 of 20 --

9 | CACI Proprietary Information
Q4 financial summary
Delivered on commitments
Healthy EBITDA1
margin
11.5% EBITDA1
margin
Free Cash Flow1
of $139 million
Strong profitability
$40M tax refund
deferred to FY26
Adjusted EPS1
+27% YoY
Strong Organic
Revenue growth
13.0% YoY growth
(5.3% organic)
Higher operating
income
Lower tax provision
and share count
Higher interest expense
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 9 of 20 --

10 | CACI Proprietary Information
FY25 financial summary
Exceptional Performance
Healthy EBITDA2
margin
11.2% EBITDA2
margin (+80 bps)
Free Cash Flow2
of $442 million
Strong profitability
$40M tax refund
deferred to FY26
Adjusted EPS2
+26% YoY
Strong Organic
Revenue growth
16% underlying1
revenue growth
(10% organic)
1 Excluding non-recurring $200M of no-margin material revenue in first half of FY24.
2 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
Higher operating
income
Lower tax provision
and share count
Higher interest expense

-- 10 of 20 --

11 | CACI Proprietary Information
Flexible and opportunistic capital deployment
Strategic M&A Capital Returns
to Shareholders
Significant optionality to deliver long-term shareholder value
1 Net debt to trailing-twelve-months (TTM) EBITDA as of June 30, 2025; pro forma includes TTM EBITDA for the Azure Summit and Applied Insight acquisitions.
2 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
Strong balance sheet (2.9x leverage1); ready access to capital
Three strategic acquisitions and a $150 million open market repurchase (OMR)
(~436k shares, or ~2% of shares outstanding, at average price ~$344/share)
$187 million of original $750 million share repurchase authorization remaining
Closed $1.0 billion upsized offering of 6.375% senior unsecured notes
Healthy long-term free cash flow2 per share growth
Internal
Investments

-- 11 of 20 --

12 | CACI Proprietary Information
FY26 guidance
This guidance represents CACI views as of August 6, 2025. Investors are reminded that actual results may
differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC.
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
2 Fiscal year 2026 free cash flow guidance assumes approximately $50 million in cash tax benefits
related to Section 174A of the One Big Beautiful Bill Act of 2025, and a $40 million tax refund
associated with prior year tax method changes.
FY26 Guidance
Revenue
(millions) $9,200 – $9,400
Adjusted
Net Income1
(millions)
$605 – $625
Adjusted
Diluted EPS1 $27.13 – $28.03
Free Cash Flow1,2
(millions) At least $710
Revenue growth of 6.6% to 8.9%
(4.3% to 6.6% organic)
Expect to deliver similar percentage of overall revenue in the first half as in
FY25 (~48%); expect relatively flat sequentially from Q1 to Q2
EBITDA1 margin in “mid 11% range”
Expect “high 10%” range in the first half
Depreciation and amortization ~$225M
Net interest expense $180M to $185M
Tax Rate 22.5% to 23.5%
Diluted shares outstanding ~22.3M
Capital expenditures of ~$85M
Expect to deliver similar percentage of overall free cash flow in the first half as
in FY25 (~25%); expect sequential growth off Q1 through rest of the year

-- 12 of 20 --

13 | CACI Proprietary Information
~84%
Existing Business
STRONG
Performance
~11%
Recompetes
HIGH
Win Rate
~5%
New Business
QUALITY
Pipeline
Long-term visibility into our business
Trailing 12-months contract awards of $10 billion
TTM Book-to-Bill of 1.1x
TTM weighted avg. duration of >5 years
Backlog of $31 billion
~3.5 years of annualized revenue
Pipeline of submitted bids: $16 billion
~80% for new business
Bids expected to be submitted
in the next two quarters: $11 billion
~75% for new business
Positive forward indicators
FY26 Revenue Composition

-- 13 of 20 --

14 | CACI Proprietary Information
• Strong performance not by accident
• Successful execution of our strategy
• CACI well aligned to the speed,
agility, and mission knowledge
required by customers
• Continued confidence in 3-year
financial targets
• Driving long-term growth in free
cash flow per share, generating
shareholder value
• Success driven by our employees’
talent, innovation, and commitment
Closing
14 | CACI Proprietary Information

-- 14 of 20 --

15 | CACI Proprietary Information
Appendix
15 | CACI Proprietary Information

-- 15 of 20 --

16 | CACI Proprietary Information
Tax expense and cash impacts
Net Income 	Cash 	Net Income 	Cash
Back-to-Back Method Change 	-	$ 	-	$ 	-	$ 	40	$
R&D Audit Settlement 	28	$ 	-	$ 	-	$ 	-	$
R&D Capitalization (Sec. 174) 	-	$ 	(47)	$ 	-	$ 	50	$
Total Tax Impacts 	28	$ 	(47)	$ 	-	$ 	90	$
($M) FY25 	FY26
• Back-to-back method change refund delayed by extended negotiations on the R&D audit
settlement
• FY25 free cash flow ahead of expectations when adjusting for the refund delay
• Payment of refund is now a matter of time and administrative process
• Favorable resolution of the R&D audit settlement results in a current period benefit and reduced
estimated tax liabilities prospectively
• Reflected in the lower tax rate guidance for FY26
• The One Big Beautiful Bill Act changed the assumption for R&D capitalization
• The legislation contained several other tax related changes, but they largely offset each other and aren’t
expected to have a material impact

-- 16 of 20 --

17 | CACI Proprietary Information
Definitions of non-GAAP measures
Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net income and GAAP
diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization expense to be indicative of our
operating performance. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating
performance, provide greater visibility in understanding the long-term financial performance of the Company, and allow investors to more easily compare our results to results of
our peers.
The Company views EBITDA and EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance, consistent with the manner in which
management measures and forecasts the Company’s performance. EBITDA is a commonly used non-GAAP measure when comparing our results with those of other companies.
We define EBITDA as GAAP net income plus net interest expense, income taxes, and depreciation and amortization expense (including depreciation within direct costs). We
consider EBITDA to be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across
reporting periods, as it eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business
combinations, which we do not believe are indicative of our operating performance. EBITDA margin is EBITDA divided by revenue.
The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated in accordance
with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain designated eligible U.S. government
receivables up to a maximum amount of $300.0 million. Free cash flow is a non-GAAP liquidity measure and may not be comparable to similarly titled measures used by other
companies. The Company defines Free cash flow as Net cash provided by operating activities excluding MARPA, less payments for capital expenditures. The Company uses these
non-GAAP measures to assess our ability to generate cash from our business operations and plan for future operating and capital actions. We believe these measures allow
investors to more easily compare current period results to prior period results and to results of our peers. Free cash flow does not represent residual cash flows available for
discretionary purposes and should not be used as a substitute for cash flow measures prepared in accordance with GAAP.
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.

-- 17 of 20 --

18 | CACI Proprietary Information
Reconciliation of net income to adjusted net income
and diluted EPS to adjusted diluted EPS (unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands, except per share data)
6/30/2025 6/30/2024 % Change 6/30/2025 6/30/2024 % Change
Net income, as reported 	157,855	$ 	134,657	$ 	17.2% 	499,830	$ 	419,924	$ 	19.0%
Intangible amortization expense 	37,405 18,626 100.8% 	124,618 73,776 68.9%
Tax effect of intangible amortization1 	(9,451) (4,575) 106.6% 	(31,486) (18,640) 68.9%
Adjusted net income 	185,809	$ 	148,708	$ 	24.9% 	592,962	$ 	475,060	$ 	24.8%
6/30/2025 6/30/2024 % Change 6/30/2025 6/30/2024 % Change
Diluted EPS, as reported 	7.14	$ 	5.98	$ 	19.4% 	22.32	$ 	18.60	$ 	20.0%
Intangible amortization expense 	1.69 	0.83 103.6% 	5.57 	3.27 70.3%
Tax effect of intangible amortization1 	(0.43) (0.20) 115.0% 	(1.41) (0.82) 72.0%
Adjusted diluted EPS 	8.40	$ 	6.61	$ 	27.1% 	26.48	$ 	21.05	$ 	25.8%
(in millions, except per share data)
Low End 	High End
Net income, as reported 	499	$ 	--- 	519	$
Intangible amortization expense 	142 --- 	142
Tax effect of intangible amortization1 	(36) --- 	(36)
Adjusted net income 	605	$ 	--- 	625	$
Low End 	High End
Diluted EPS, as reported 	22.38	$ 	--- 	23.27	$
Intangible amortization expense 	6.37 --- 	6.37
Tax effect of intangible amortization1 	(1.61) --- 	(1.61)
Adjusted diluted EPS 	27.13	$ 	--- 	28.03	$
FY25 Guidance Range
FY25 Guidance Range
Three Months Ended 	Twelve Months Ended
Three Months Ended 	Twelve Months Ended
(1) Calculation uses an assumed full year statutory tax rate of 25.3% and 25.3% on non-GAAP tax deductible adjustments for FY 25 and
FY24, respectively.
Note: Numbers may not sum due to rounding.

-- 18 of 20 --

19 | CACI Proprietary Information
Reconciliation of net income to earnings before interest,
taxes, depreciation and amortization (EBITDA) (unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	6/30/2025 6/30/2024 % Change 6/30/2025 6/30/2024 % Change
Net income 	157,855	$ 	134,657	$ 	17.2% 499,830	$ 	419,924	$ 19.0%
Plus:
Income taxes 	3,131 38,792 -91.9% 105,511 124,725 -15.4%
Interest income and expense, net 	45,691 24,301 88.0% 158,844 105,059 51.2%
Depreciation and amortization expense,
including amounts within direct costs 57,861 37,125 55.9% 202,611 148,293 36.6%
EBITDA 	264,538	$ 	234,875	$ 	12.6% 966,796	$ 	798,001	$ 21.2%
(in thousands) 	6/30/2025 6/30/2024 % Change 6/30/2025 6/30/2024 % Change
Revenues, as reported 	2,304,144	$ 2,038,295	$ 	13.0% 8,627,824	$ 7,659,832	$ 12.6%
EBITDA 	264,538 234,875 12.6% 966,796 798,001 21.2%
EBITDA margin 	11.5% 11.5% 	11.2% 10.4%
Three Months Ended 	Twelve Months Ended
Three Months Ended 	Twelve Months Ended

-- 19 of 20 --

20 | CACI Proprietary Information
Reconciliation of net cash provided by operating activities to net cash provided
by operating activities excluding MARPA and to free cash flow (unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	6/30/2025 6/30/2024 6/30/2025 6/30/2024
Net cash provided by operating activities 	155,982	$ 	157,208	$ 	547,009	$ 	497,331	$
Cash used in (provided by) MARPA 	11,091 - 	(38,909) (50,000)
Net cash provided by operating activities excluding MARPA 167,073 157,208 	508,100 447,331
Capital expenditures 	(27,963) (22,595) (65,603) (63,686)
Free cash flow 	139,110	$ 	134,613	$ 	442,497	$ 	383,645	$
(in millions)
Net cash provided by operating activities 	795	$
Cash used in (provided by) MARPA 	-
Net cash provided by operating activities excluding MARPA 	795
Capital expenditures 	(85)
Free cash flow 	710	$
Three Months Ended Twelve Months Ended
FY26
Current
Guidance

-- 20 of 20 --